Taurolidine: could this be the 'silver bullet' against cardiac implantable electronic device infection?

Europace

Professor of Medicine, Johns Hopkins Hospital and School of Medicine, 600 N. Wolfe St/Halsted 567, Baltimore, MD 21287, USA.

Published: November 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651068PMC
http://dx.doi.org/10.1093/europace/euad332DOI Listing

Publication Analysis

Top Keywords

taurolidine 'silver
4
'silver bullet'
4
bullet' cardiac
4
cardiac implantable
4
implantable electronic
4
electronic device
4
device infection?
4
taurolidine
1
bullet'
1
cardiac
1

Similar Publications

Consensus on Wound Antisepsis: Update 2018.

Skin Pharmacol Physiol

August 2018

Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

Wound antisepsis has undergone a renaissance due to the introduction of highly effective wound-compatible antimicrobial agents and the spread of multidrug-resistant organisms (MDROs). However, a strict indication must be set for the application of these agents. An infected or critically colonized wound must be treated antiseptically.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!